Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease

被引:15
作者
Carapelle, Elena [1 ]
Mundi, Ciro [1 ]
Cassano, Tommaso [2 ]
Avolio, Carlo [1 ,3 ]
机构
[1] United Hosp Foggia, Dept Neurosci, I-71100 Foggia, Italy
[2] Univ Foggia, Dept Clin & Expt Med, I-71100 Foggia, Italy
[3] Univ Foggia, Dept Med & Surg Sci, I-71100 Foggia, Italy
关键词
cognitive reserve; Alzheimer disease; CSF biomarkers; CEREBROSPINAL-FLUID BIOMARKERS; PHOSPHORYLATED TAU-PROTEIN; SYNAPSE LOSS; CSF BIOMARKERS; BRAIN ACTIVITY; DEMENTIA; EDUCATION; AGE; NEUROPATHOLOGY; IMPAIRMENT;
D O I
10.3390/ijms21176279
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Patients with comparable degree of neuropathology could show different cognitive impairments. This could be explained with the concept of cognitive reserve (CR), which includes a passive and an active component. In particular, CR is used to explain the gap between tissue damage and clinical symptoms that has been observed in dementia and, in particular, in patients affected by Alzheimer disease (AD). Different studies confirm brain neuroplasticity. Our preliminary study demonstrated that AD patients with high education showed a CR inversely associated with glucose uptake measured in fluorodeoxyglucose positron emission tomography (FDG-PET), whereas the inverse correlation was observed in AD patients with low education. In other words, our findings suggest that CR compensates the neurodegeneration and allows the maintenance of patients' cognitive performance. Best understanding of the concept of CR could lead to interventions to slow cognitive aging or reduce the risk of dementia.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 78 条
  • [1] ARE NEW NEURONS FORMED IN BRAINS OF ADULT MAMMALS
    ALTMAN, J
    [J]. SCIENCE, 1962, 135 (3509) : 1127 - &
  • [2] [Anonymous], 1993, Neuropsychology, DOI [DOI 10.1037/0894-4105.7.3.273, 10.1037/0894-4105.7.3.273]
  • [3] Resistance vs resilience to Alzheimer disease Clarifying terminology for preclinical studies
    Arenaza-Urquijo, Eider M.
    Vemuri, Prashanthi
    [J]. NEUROLOGY, 2018, 90 (15) : 695 - 703
  • [4] Linking cognitive aging to alterations in dopamine neurotransmitter functioning: Recent data and future avenues
    Backman, Lars
    Lindenberger, Ulman
    Li, Shu-Chen
    Nyberg, Lars
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2010, 34 (05) : 670 - 677
  • [5] Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis
    Bigio, EH
    Hynan, LS
    Sontag, E
    Satumtira, S
    White, CL
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (03) : 218 - 227
  • [6] CSF total tau, aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
    Blennow, K
    Vanmechelen, E
    Hampel, H
    [J]. MOLECULAR NEUROBIOLOGY, 2001, 24 (1-3) : 87 - 97
  • [7] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    Blennow, Kaj
    Hampel, Harald
    Weiner, Michael
    Zetterberg, Henrik
    [J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (03) : 131 - 144
  • [8] STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES
    BRAAK, H
    BRAAK, E
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (03) : 271 - 278
  • [9] Braak H, 1996, ACTA NEUROL SCAND, V93, P3
  • [10] Education, the brain and dementia: neuroprotection or compensation?
    Brayne, Carol
    Ince, Paul G.
    Keage, Hannah A. D.
    McKeith, Ian G.
    Matthews, Fiona E.
    Polvikoski, Tuomo
    Sulkava, Raimo
    [J]. BRAIN, 2010, 133 : 2210 - 2216